Stay tuned for our LIVE OncLive News Network coverage straight from the #ASH18 conference floor! 

Dr. Arber on Aspirin for Colorectal Cancer Prevention

Nadir Arber, MD, MHA
Published: Monday, Jul 27, 2015



Nadir Arber, MD, MHA, Yechiel and Helen Lieber Chair for Cancer Research at Tel Aviv Sourasky Medical Center and Tel Aviv University, Sackler School of Medicine, Professor of Medicine and Gastroenterology and Director of the Integrated Cancer Prevention Center (ICPC) in Tel-Aviv Medical Center, discusses the role of aspirin in the prevention of colorectal cancer.

Aspirin is often researched as a preventative method individually for Alzheimer's, heart disease, and colorectal cancer. However research should be focused on overall mortality across diseases, and not focused on specific individual diseases, says Arber.

Aspirin has a good safety profile, and should be recommended to most who are at high-risk for colorectal cancer. However, risk should be carefully calculated, as there are some negative effects for certain patients populations, says Arber. Further research is needed to determine the optimal patient population who will most benefit from aspirin.



Nadir Arber, MD, MHA, Yechiel and Helen Lieber Chair for Cancer Research at Tel Aviv Sourasky Medical Center and Tel Aviv University, Sackler School of Medicine, Professor of Medicine and Gastroenterology and Director of the Integrated Cancer Prevention Center (ICPC) in Tel-Aviv Medical Center, discusses the role of aspirin in the prevention of colorectal cancer.

Aspirin is often researched as a preventative method individually for Alzheimer's, heart disease, and colorectal cancer. However research should be focused on overall mortality across diseases, and not focused on specific individual diseases, says Arber.

Aspirin has a good safety profile, and should be recommended to most who are at high-risk for colorectal cancer. However, risk should be carefully calculated, as there are some negative effects for certain patients populations, says Arber. Further research is needed to determine the optimal patient population who will most benefit from aspirin.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Oncology Best Practice™ Decision Points in Advanced NSCLC: Assessing Treatment Options Beyond Disease ProgressionNov 30, 20181.0
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x